The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Open accessAbstract
We analysed whole-genome sequences of 560 breast cancers to advance understanding of the driver mutations conferring clonal advantage and the mutational processes generating somatic mutations. We found that 93 protein-coding cancer genes carried probable driver mutations. Some non-coding regions exhibited high mutation frequencies, but most have distinctive structural features probably causing elevated mutation rates and do not contain driver mutations. Mutational signature analysis was extended to genome rearrangements and revealed twelve base substitution and six rearrangement signatures. Three rearrangement signatures, characterized by tandem duplications or deletions, appear associated with defective homologous-recombination-based DNA repair: one with deficient BRCA1 function, another with deficient BRCA1 or BRCA2 function, the cause of the third is unknown. This analysis of all classes of somatic mutation across exons, introns and intergenic regions highlights the repertoire of cancer genes and mutational processes operating, and progresses towards a comprehensive account of the somatic genetic basis of breast cancer. Whole-genome sequencing of tumours from 560 breast cancer cases provides a comprehensive genome-wide view of recurrent somatic mutations and mutation frequencies across both protein coding and non-coding regions; several mutational signatures in these cancer genomes are associated with BRCA1 or BRCA2 function and defective homologous-recombination-based DNA repair. This study reports whole-genome sequencing of tumours and normal tissue from 560 breast cancer cases, providing a comprehensive genome-wide view of recurrent somatic mutations and mutation frequencies across both protein coding and non-coding regions. The authors analyse mutational signatures in these cancer genomes, including a new investigation of rearrangement mutational processes, and find several that are associated with BRCA1 or BRCA2 function and defective homologous-recombination-based DNA repair. They also find mutational signatures showing distinct DNA replication strand biases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, BRCA inactivation is known to promote genomic instability through homologous recombination deficiencies in several solid tumors such as breast and ovarian cancer.47”
From Evolution of Multiple Myeloma from a Genomic Perspective (2026) · cites this paper as [47]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Indeed, some mutational footprints were found to be associated with BRCA1/2 deficiency, namely deletions with flanking microhomology, as well as several “mutational signatures” including two COSMIC single nucleotide variant (SNV) signatures and two structural variant (SV) signatures8.”
From Pan-cancer landscape of homologous recombination deficiency. (2020) · cites this paper as [8]
In the citing paper
“These genomic features in the SCAN-B TNBC cohort were comparable to a previously reported WGS cohort8”
From Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study (2019) · cites this paper as [8]
In the citing paper
“Five substitution and five rearrangement signatures [8, 9] were identified”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“Seventy-nine out of the 93 previously identified BC driver genes [9] were mutated”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“Despite the role of TP53, ATM and CHEK2 in DNA-damage signalling and double-strand breaks detection, these tumours do not show evidence of BRCA-deficient signatures, as previously described [9, 13, 19], but instead they harbour highly complex clustered chromosomal rearrangements.”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“The variant was not reported in gnomAD or in the 560 BC genomes cohort [9] and is described by ClinVar (Variation ID: 135816) as ‘Class 3 Uncertain significance’”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“Loss of function of BRCA1, BRCA2 and PALB2 yield a high mutation burden and specific signatures inferring defective HR [7, 9, 10, 13].”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“These clustered events coincided with amplifications of known BC oncogenes (e.g. ZNF217, ERBB2, CCND1, MYC) [9]”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Self-citationNishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,239
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Self-citationVelvet: Algorithms for de novo short read assembly using de Bruijn graphsPreprint
Zerbino, D. R., & Birney, E. (2008) · Genome Research · doi:10.1101/gr.074492.107 · Cited by 9,575
Self-citationThe genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Self-citationConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Wilkerson, M. D., & Hayes, D. N. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq170 · Cited by 5,645
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Cited by
Sorted by citations
Items 601–700 of 1,002
Identification of frequent somatic mutations in inflammatory breast cancer
Matsuda, N., Lim, B., Wang, Y., Krishnamurthy, S., Woodward, W. A., Álvarez, R. H., Lucci, A., Valero, V., Reuben, J. M., Meric‐Bernstam, F., et al. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4165-0 · Cited by 42
Self-citationGenetic and clinical landscape of breast cancers with germline BRCA1/2 variants
Inagaki‐Kawata, Y., Yoshida, K., Kawaguchi‐Sakita, N., Kawashima, M., Nishimura, T., Senda, N., Shiozawa, Y., Takeuchi, Y., Inoue, Y., Sato‐Otsubo, A., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01301-9 · Cited by 44
Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor
Slotkin, E. K., Bowman, A. S., Levine, M. F., Cruz, F. S. D., Coutinho, D. F., Sanchez, G. D. I., Rosales, N., Modak, S. I., Tap, W. D., Gounder, M. M., et al. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0722 · Cited by 42
Ewing, A., Meynert, A. M., Churchman, M., Grimes, G. R., Hollis, R. L., Herrington, C. S., Rye, T., Bartos, C., Croy, I., Ferguson, M., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4068 · Cited by 40
Breast Cancer Heterogeneity in Primary and Metastatic Disease
Kalinowski, L., Saunus, J. M., Reed, A. E. M., & Lakhani, S. R. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-20301-6_6 · Cited by 47
Self-citationPatterns of structural variation in human cancerPreprint
Li, Y.-L., Roberts, N. D., Weischenfeldt, J., Wala, J., Shapira, O., Schumacher, S., Khurana, E., Korbel, J., Imieliński, M., Beroukhim, R., et al. (2017) · bioRxiv · doi:10.1101/181339 · Cited by 48
Self-citationSherill-Rofe, D., Rahat, D., Findlay, S., Mellul, A., Guberman, I., Braun, M., Bloch, I., Lalezari, A., Samiei, A., Sadreyev, R. I., et al. (2019) · Genome Research · doi:10.1101/gr.241414.118 · Cited by 39
A living biobank of canine mammary tumor organoids as a comparative model for human breast cancer
Inglebert, M., Dettwiler, M., Hahn, K., Letko, A., Drögemüller, C., Doench, J. G., Brown, A., Memari, Y., Davies, H. R., Degasperi, A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-21706-2 · Cited by 43
Self-citationMattos‐Arruda, L. D., Ng, C. K. Y., Piscuoglio, S., González‐Cao, M., Lim, R. S., Filippo, M. R. D., Fusco, N., Schultheis, A. M., Ortiz, C., Viteri, S., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25041 · Cited by 41
Prioritization and functional assessment of noncoding variants associated with complex diseases
Zhou, L., & Zhao, F. (2018) · Genome Medicine · doi:10.1186/s13073-018-0565-y · Cited by 41
DNA repair defects in prostate cancer: impact for screening, prognostication and treatment
Warner, E. W., Yip, S., Chi, K. N., & Wyatt, A. W. (2018) · British Journal of Urology · doi:10.1111/bju.14576 · Cited by 42
Non-coding RNAs underlie genetic predisposition to breast cancer
Marjaneh, M. M., Beesley, J., O’Mara, T. A., Mukhopadhyay, P., Koufariotis, L. T., Kazakoff, S. H., Hussein, N., Fachal, L., Bartoniček, N., Hillman, K. M., et al. (2020) · Genome biology · doi:10.1186/s13059-019-1876-z · Cited by 40
Self-citationLee, S., Hu, Y., Loo, S. K., Tan, Y., Bhargava, R., Lewis, M. T., & Wang, X. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921333117 · Cited by 42
Katz‐Summercorn, A., Jammula, S., Frangou, A., Peneva, I., O’Donovan, M., Tripathi, M., Malhotra, S., di Pietro, M., Abbas, S., Devonshire, G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28237-4 · Cited by 36
Self-citationA commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor
Mei, W., Tabrizi, S. F., Godina, C., Lovisa, A. F., Isaksson, K., Jernström, H., & Tavazoie, S. F. (2024) · Cell · doi:10.1016/j.cell.2024.11.009 · Cited by 43
The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas
Moukarzel, L. A., Ferrando, L., Paula, A. D. C., Brown, D. N., Geyer, F. C., Pareja, F. G., Piscuoglio, S., Papanastasiou, A. D., Fusco, N., Marchiò, C., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12813 · Cited by 39
Self-citationZhao, H., Han, B., Li, X., Sun, C., Zhai, Y., Li, M., Jiang, M., Zhang, W., Liang, Y., & Kai, G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.872085 · Cited by 40
Rheinbay, E., Nielsen, M. M., Abascal, F., Tiao, G., Hornshøj, H., Hess, J. M., Pedersen, R. I., Feuerbach, L., Sabarinathan, R., Madsen, T. L., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/237313 · Cited by 40
Self-citationKasuga, A., Okamoto, T., Udagawa, S., Mori, C., Mie, T., Furukawa, T., Yamada, Y., Takeda, T., Matsuyama, M., Sasaki, T., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031205 · Cited by 41
Basyuni, S., Heskin, L., Degasperi, A., Black, D., Koh, C. C., Chmelova, L., Rinaldi, G., Bell, S., Grybowicz, L., Elgar, G., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51577-2 · Cited by 44
Self-citationNEAT1-containing paraspeckles: Central hubs in stress response and tumor formation
Adriaens, C., & Marine, J. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1235847 · Cited by 39
Next-Generation Proteomics and Its Application to Clinical Breast Cancer Research
Mardamshina, M., & Geiger, T. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.07.003 · Cited by 45
Shin, S., Müller, A., Verma, N., Lev, S., & Nguyen, L. K. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006192 · Cited by 39
Chartron, E., Theillet, C. G., Guiu, S., & Jacot, W. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.10.012 · Cited by 40
RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia
Gassner, F. J., Zaborsky, N., Buchumenski, I., Levanon, E. Y., Gatterbauer, M., Schubert, M., Rauscher, S., Hebenstreit, D., Nadeu, F., Campo, E., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0995-6 · Cited by 39
Davies, H. R., Broad, K. D., Onadim, Z., Price, E. A., Zou, X., Sheriff, I., Karaa, E. K., Scheimberg, I. B., Reddy, M. A., Sagoo, M. S., et al. (2021) · Cancers · doi:10.3390/cancers13040754 · Cited by 39
Self-citationLuo, R., Chong, W., Wei, Q., Zhang, Z., Wang, C., Ye, Z., Abu-Khalaf, M. M., Silver, D. P., Stapp, R., Jiang, W. I., et al. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00278-w · Cited by 39
Hoogstraat, M., Lips, E. H., Mayayo‐Peralta, I., Mulder, L., Kristel, P., van der Heijden, I., Annunziato, S., van Seijen, M., Nederlof, P. M., Sonke, G. S., et al. (2022) · npj Breast Cancer · doi:10.1038/s41523-022-00428-8 · Cited by 41
Cheung, A., Chenoweth, A. M., Johansson, A., Laddach, R., Guppy, N., Trendell, J., Esapa, B., Mavousian, A., Navarro‐Llinas, B., Haider, S. A., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-3110 · Cited by 38
Self-citationGirnius, N., & Davis, R. J. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.067 · Cited by 38
Shull, J. D., Dennison, K. L., Chack, A. C., & Trentham‐Dietz, A. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00105.2017 · Cited by 38
Lin, C., Beattie, A., Baradaran, B., Dray, E. V., & Duijf, P. H. G. (2018) · Scientific Reports · doi:10.1038/s41598-018-32272-x · Cited by 38
Mechanisms of resistance to estrogen receptor modulators in ER+/HER2− advanced breast cancer
Zhang, J., Wang, Q., Wang, Q., Cao, J., Sun, J., & Zhu, Z. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03281-4 · Cited by 40
Tsai, Y., Huang, C., Lin, Y., Hsu, C., Huang, C.-P., Liu, C., Chiu, J., & Tseng, L. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02867-x · Cited by 39
De novo mutational signature discovery in tumor genomes using SparseSignatures
Lal, A., Liu, K., Tibshirani, R. J., Sidow, A., & Ramazzotti, D. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009119 · Cited by 39
Molecular Pathways: Understanding and Targeting Mutant Spliceosomal Proteins
Yoshimi, A., & Abdel-Wahab, O. I. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0131 · Cited by 39
Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors
Marotta, M. L., Onodera, T., Johnson, J. E., Budd, G. T., Watanabe, T., Cui, X., Giuliano, A. E., Niida, A., & Tanaka, H. (2017) · Scientific Reports · doi:10.1038/srep41921 · Cited by 38
Meijer, T. G., Nguyen, L., van Hoeck, A., Sieuwerts, A. M., Verkaik, N. S., Ladan, M. M., Ruigrok-Ritstier, K., van Deurzen, C. H. M., van de Werken, H. J. G., Lips, E. H., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02363-1 · Cited by 36
Self-citationMultimodal Omics Approaches to Aging and Age-Related Diseases
Ji, Q., Jiang, X., Wang, M., Xin, Z., Zhang, W., Qu, J. T., & Liu, G. (2024) · Phenomics · doi:10.1007/s43657-023-00125-x · Cited by 39
Complex rearrangements fuel ER+ and HER2+ breast tumours
Houlahan, K. E., Mangiante, L., Sotomayor-Vivas, C., Adimoelja, A., Park, S., Khan, A., Pribus, S. J., Ma, Z., Caswell-Jin, J. L., & Curtis, C. N. (2025) · Nature · doi:10.1038/s41586-024-08377-x · Cited by 38
CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer
Stefánsson, Ó. A., Hermanowicz, S., van der Horst, J., Hilmarsdóttir, H., Staszczak, Z., Jonasson, J. G., Tryggvadóttír, L., Guðjόnsson, Þ., & Sigurðsson, S. (2017) · BMC Cancer · doi:10.1186/s12885-017-3453-8 · Cited by 38
Somatic mutations in early onset luminal breast cancer
Encinas, G., Sabelnykova, V. Y., de Lyra, E. C., Katayama, M. L. H., Maistro, S., Valle, P. W. M. D. V., Pereira, G. F. D. L., Rodrigues, L. M., Serio, P. A. D. M. P., de Gouvêa, A. C. R. C., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25123 · Cited by 37
Basal-like Breast Cancers: From Pathology to Biology and Back Again
Gusterson, B. A., & Eaves, C. J. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.04.023 · Cited by 37
Targeted mutation detection in breast cancer using MammaSeq™
Smith, N. G., Gyanchandani, R., Shah, O. S., Gurda, G. T., Lucas, P. C., Hartmaier, R. J., Brufsky, A., Puhalla, S., Bahreini, A., Kota, K. J., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1102-7 · Cited by 36
Undifferentiated pleomorphic sarcomas with PRDM10 fusions have a distinct gene expression profile
Hofvander, J., Puls, F., Pillay, N., Steele, C. D., Flanagan, A. M., Magnusson, L., Nilsson, J., & Mertens, F. (2019) · The Journal of Pathology · doi:10.1002/path.5326 · Cited by 37
Svedlund, J., Strell, C., Qian, X., Zilkens, K. J. C., Tobin, N. P., Bergh, J. C. S., Sieuwerts, A. M., & Nilsson, M. F. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.009 · Cited by 35
Self-citationThe genomic and epigenomic evolutionary history of papillary renal cell carcinomas
Zhu, B., Poeta, M. L., Costantini, M., Zhang, T., Shi, J., Sentinelli, S., Wei, Z., Pompeo, V., Cardelli, M., Alexandrov, B. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16546-5 · Cited by 38
Self-citationSztupinszki, Z. M., Dióssy, M., Börcsök, J., Prósz, A. G., Cornelius, N., Kjeldsen, M. K., Mirza, M. R., & Szállási, Z. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0981 · Cited by 37
van Wijk, L. M., Nilas, A. B., Vrieling, H., & Vreeswijk, M. P. G. (2021) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2022.2020102 · Cited by 41
Cholesterol and Its Derivatives: Multifaceted Players in Breast Cancer Progression
Centonze, G., Natalini, D., Piccolantonio, A., Salemme, V., Morellato, A., Arina, P., Riganti, C., & Defilippi, P. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.906670 · Cited by 43
Two-ended recombination at a Flp-nickase-broken replication fork
Elango, R., Nilavar, N. M., Li, A. G., Nguyen, D., Rass, E., Duffey, E. E., Jiang, Y., Abakir, A., Willis, N. A., Houseley, J. M., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.11.006 · Cited by 33
Molecular analysis of PALB2‐associated breast cancers
Lee, J. E. A., Li, N., Rowley, S. M., Cheasley, D. A., Zethoven, M., McInerny, S., Gorringe, K. L., James, P. A., & Campbell, I. (2018) · The Journal of Pathology · doi:10.1002/path.5055 · Cited by 36
Self-citationDzobo, K., Rowe, A., Senthebane, D. A., AlMazyadi, M., Patten, V. A., & Parker, M. I. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2018.0172 · Cited by 37
The Landscape of Somatic Genetic Alterations in Breast Cancers from CHEK2 Germline Mutation Carriers
Mandelker, D. L., Kumar, R., Pei, X., Selenica, P., Setton, J. S., Arunachalam, S., Ceyhan‐Birsoy, O., Brown, D. N., Norton, L., Robson, M. E., et al. (2019) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkz027 · Cited by 36
Double Agent: SPDEF Gene with Both Oncogenic and Tumor-Suppressor Functions in Breast Cancer
Ye, T., Feng, J. Y., Wan, X., Xie, D., & Liu, J. (2020) · Cancer Management and Research · doi:10.2147/cmar.s243748 · Cited by 35
Muyas, F., Zapata, L., Guigó, R., & Ossowski, S. (2020) · Genome Medicine · doi:10.1186/s13073-020-00746-1 · Cited by 37
Stefánsson, Ó. A., Hilmarsdóttir, H., Ólafsdóttir, K., Tryggvadóttír, L., Sverrisdóttir, Á., Johannsson, O. T., Jonasson, J. G., Eyfjord, J. E., & Sigurðsson, S. (2019) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkz100 · Cited by 35
Self-citationSanchez, A., Ortega, P., Sakhtemani, R., Manjunath, L., Oh, S., Bournique, E., Becker, A., Kim, K., Durfee, C. C., Temiz, N. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45909-5 · Cited by 39
The prognostic effect of DDX3 upregulation in distant breast cancer metastases
van Voss, M. R. H., Schrijver, W. A. M. E., ter Hoeve, N. D., Hoefnagel, L. D. C., Manson, Q. F., van der Wall, E., Raman, V., & van Diest, P. J. (2016) · Clinical & Experimental Metastasis · doi:10.1007/s10585-016-9832-8 · Cited by 35
Onco-proteogenomics: Multi-omics level data integration for accurate phenotype prediction
Dimitrakopoulos, L., Prassas, I., Diamandis, E. P., & Charames, G. S. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1384446 · Cited by 36
Andersen, G. B., & Tost, J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7481-8_1 · Cited by 36
Hodel, K. P., de Borja, R., Henninger, E. E., Campbell, B. B., Ungerleider, N., Light, N. D., Wu, T., LeCompte, K. G., Goksenin, A. Y., Bunnell, B. A., et al. (2018) · eLife · doi:10.7554/elife.32692 · Cited by 35
Coexisting genomic aberrations associated with lymph node metastasis in breast cancer
Bao, L., Qian, Z., Lyng, M., Wang, L., Yu, Y., Wang, T., Zhang, X., Yang, H., Brünner, N., Wang, J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97449 · Cited by 35
Nguyen, B., Venet, D., Azim, H. A., Brown, D. N., Desmedt, C., Lambertini, M., Majjaj, S., Pruneri, G., Peccatori, F. A., Piccart, M. J., et al. (2018) · npj Breast Cancer · doi:10.1038/s41523-018-0077-3 · Cited by 35
Self-citationRecent advances in breast cancer research impacting clinical diagnostic practice
Reed, A. E. M., Croft, P. K., Kutasovic, J. R., Saunus, J. M., & Lakhani, S. R. (2018) · The Journal of Pathology · doi:10.1002/path.5199 · Cited by 34
Self-citationConstitutional Mosaic Epimutations – a hidden cause of cancer?
Lønning, P. E., Eikesdal, H. P., Løes, I. M., & Knappskog, S. (2019) · Cell Stress · doi:10.15698/cst2019.04.183 · Cited by 33
Self-citationEpigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome
Davies, H. R., Hodgson, K., Schwalbe, E. C., Coxhead, J., Sinclair, N., Zou, X., Cockell, S., Husain, A., Nik‐Zainal, S., & Rajan, N. (2019) · Nature Communications · doi:10.1038/s41467-019-12746-w · Cited by 39
Self-citationBertucci, F., Rypens, C., Finetti, P., Guillé, A., Adélaı̈de, J., Monneur, A., Carbuccia, N., Garnier, S., Dirix, P. R., Gonçalvès, A., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12621 · Cited by 35
Self-citationGenetics and Genomics of Breast Cancer: update and translational perspectives
Biancolella, M., Testa, B., Salehi, L. B., D’Apice, M. R., & Novelli, G. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.03.013 · Cited by 34
Drivers underpinning the malignant transformation of giant cell tumour of bone
Fittall, M. W., Lyskjær, I., Ellery, P., Lombard, P., Ijaz, J., Strobl, A., Oukrif, D., Tarabichi, M., Sill, M., Koelsche, C., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5537 · Cited by 35
Self-citationRichard, F., Majjaj, S., Venet, D., Rothé, F., Pingitore, J., Boeckx, B., Marchiò, C., Clatot, F., Bertucci, F., Mariani, O., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2268 · Cited by 35
Self-citationBörcsök, J., Sztupinszki, Z. M., Bekele, R., Gao, S. P., Dióssy, M., Samant, A. S., Dillon, K. M., Tisza, V., Spisák, S., Rusz, O., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3316 · Cited by 35
Mechanistic origins of diverse genome rearrangements in cancer
Dahiya, R., Hu, Q., & Ly, P. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.03.003 · Cited by 34
MYC amplifications are common events in childhood osteosarcoma
Noon, S. D., Ijaz, J., Coorens, T. H. H., Amary, F. M., Ye, H., Strobl, A., Lyskjær, I., Flanagan, A. M., & Behjati, S. (2021) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.219 · Cited by 34
Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer
Bonazzi, V., Kondrashova, O., Smith, D. S., Nones, K., Sengal, A. T., Ju, R. J., Packer, L., Koufariotis, L. T., Kazakoff, S. H., Davidson, A. L., et al. (2022) · Genome Medicine · doi:10.1186/s13073-021-00990-z · Cited by 34
Looking beyond drivers and passengers in cancer genome sequencing data
De, S., & Ganesan, S. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw677 · Cited by 36
CRISPR screens identify gene targets at breast cancer risk loci
Tuano, N. K., Beesley, J., Manning, M., Shi, W., Perlaza-Jimenez, L., Malaver-Ortega, L. F., Paynter, J. M., Black, D., Civitarese, A., McCue, K., et al. (2023) · Genome Biology · doi:10.1186/s13059-023-02898-w · Cited by 30
Hacking, S. M., Yakirevich, E., & Wang, Y. (2022) · Cancers · doi:10.3390/cancers14143469 · Cited by 40
Kretová, M., Selicky, T., Čipáková, I., & Čipák, L. (2023) · Life · doi:10.3390/life13030604 · Cited by 37
Coorens, T. H. H., Collord, G., Treger, T. D., Adams, S. P., Mitchell, E., Newman, B., Getz, G. A., Godfrey, A. L., Bartram, J. L., & Behjati, S. (2023) · Nature Cancer · doi:10.1038/s43018-023-00604-0 · Cited by 37
Williams, M. J., Oliphant, M. U. J., Au, V., Liu, C., Baril, C., O’Flanagan, C., Lai, D., Beatty, S., Van Vliet, M., Yiu, J. C., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01988-0 · Cited by 34
Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer
Hillman, R. T., Chisholm, G. B., Lu, K. H., & Futreal, P. A. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx176 · Cited by 34
Self-citationComprehensive analysis of the aberrantly expressed lncRNA‑associated ceRNA network in breast cancer
Tuersong, T., Li, L., Abulaiti, Z., & Feng, S. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10165 · Cited by 34
DSS1 interacts with and stimulates RAD52 to promote the repair of DSBs
Štefanovie, B., Hengel, S. R., Mlčoušková, J., Prochazkova, J., Špı́rek, M., Nikulenkov, F., Němeček, D., Koch, B. G., Bain, F. E., Yu, L. P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1052 · Cited by 34
Immunohistochemical assessment of HRAS Q61R mutations in breast adenomyoepitheliomas
Pareja, F. G., Toss, M. S., Geyer, F. C., da Silva, E. M., Vahdatinia, M., Sebastião, A. P. M., Selenica, P., Szatrowski, A., Edelweiss, M., Wen, H. Y., et al. (2019) · Histopathology · doi:10.1111/his.14057 · Cited by 34
Roelofs, P. A., Goh, C. Y., Chua, B. H., Jarvis, M. C., Stewart, T. A., McCann, J. L., McDougle, R. M., Carpenter, M. A., Martens, J. W. M., Span, P. N., et al. (2020) · eLife · doi:10.7554/elife.61287 · Cited by 33
Self-citationHobbs, E. A., Litton, J. K., & Yap, T. A. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1952181 · Cited by 35
Aberrant RNA splicing and therapeutic opportunities in cancers
Yamauchi, H., Nishimura, K., & Yoshimi, A. (2021) · Cancer Science · doi:10.1111/cas.15213 · Cited by 33
Rogozin, I. B., Lada, A. G., Goncearenco, A., Green, M. R., De, S., Nudelman, G., Panchenko, A. R., Koonin, E. V., & Pavlov, Y. I. (2016) · Scientific Reports · doi:10.1038/srep38133 · Cited by 33
de Oliveira, K. A., Sengupta, S., Yadav, A. K., & Clarke, R. C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1083048 · Cited by 32
Casado, P., Rio‐Machín, A., Miettinen, J. J., Bewicke‐Copley, F., Rouault‐Pierre, K., Krizsán, S., Parsons, A., Rajeeve, V., Miraki‐Moud, F., Taussig, D. C., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01288-1 · Cited by 32
Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications
Tierno, D., Grassi, G., Scomersi, S., Bortul, M., Generali, D., Zanconati, F., & Scaggiante, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119688 · Cited by 33
Risks at the DNA Replication Fork: Effects upon Carcinogenesis and Tumor Heterogeneity
Mertz, T. M., Harcy, V., & Roberts, S. A. (2017) · Genes · doi:10.3390/genes8010046 · Cited by 34
Sanderson, M. P., Hofmann, M. H., Garin‐Chesa, P., Schweifer, N., Wernitznig, A., Fischer, S., Jeschko, A., Meyer, R., Moll, J., Pecina, T., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0336 · Cited by 32
Short inverted repeats contribute to localized mutability in human somatic cells
Zou, X., Morganella, S., Głodzik, D., Davies, H. R., Li, Y., Stratton, M. R., & Nik‐Zainal, S. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx731 · Cited by 33
Self-citationBig Data Approaches for Modeling Response and Resistance to Cancer Drugs
Jiang, P., Sellers, W. R., & Liu, X. S. (2018) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-080917-013350 · Cited by 32
Guo, F., Zhu, X., Zhao, Q., & Huang, Q. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4666 · Cited by 33
Chromothripsis in Human Breast Cancer
Bolkestein, M., Wong, J., Thewes, V., Körber, V., Hlevnjak, M., Elgaafary, S., Schulze, M., Kommoss, F. K. F., Sinn, H., Anzeneder, T., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1920 · Cited by 33
Discovery of driver non-coding splice-site-creating mutations in cancer
Cao, S., Zhou, D. C., Oh, C., Jayasinghe, R. G., Zhao, Y., Yoon, C. J., Wyczalkowski, M. A., Bailey, M. H., Tsou, T. C., Gao, Q., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19307-6 · Cited by 35
Molecular Heterogeneity and Evolution in Breast Cancer
Caswell-Jin, J. L., Lorenz, C., & Curtis, C. N. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-060220-014137 · Cited by 32
Metadata
- Authors
- Nik-Zainal, S., Davies, H., Staaf, J., Ramakrishna, M., Glodzik, D., Zou, X., Martincorena, I., Alexandrov, L. B., Martin, S., Wedge, D. C., Van Loo, P., Ju, Y. S., Smid, M., Brinkman, A. B., Morganella, S., Aure, M. R., Lingjærde, O. C., Langerød, A., Ringnér, M., Ahn, S.-M., Boyault, S., Brock, J. E., Broeks, A., Butler, A., Desmedt, C., Dirix, L., Dronov, S., Fatima, A., Foekens, J. A., Gerstung, M., Hooijer, G. K. J., Jang, S. J., Jones, D. R., Kim, H.-Y., King, T. A., Krishnamurthy, S., Lee, H. J., Lee, J.-Y., Li, Y., McLaren, S., Menzies, A., Mustonen, V., O’Meara, S., Pauporté, I., Pivot, X., Purdie, C. A., Raine, K., Ramakrishnan, K., Rodríguez-González, F. G., Romieu, G., Sieuwerts, A. M., Simpson, P. T., Shepherd, R., Stebbings, L., Stefansson, O. A., Teague, J., Tommasi, S., Treilleux, I., Van den Eynden, G. G., Vermeulen, P., Vincent-Salomon, A., Yates, L., Caldas, C., Veer, L. V., Tutt, A., Knappskog, S., Tan, B. K. T., Jonkers, J., Borg, Å., Ueno, N. T., Sotiriou, C., Viari, A., Futreal, P. A., Campbell, P. J., Span, P. N., Van Laere, S., Lakhani, S. R., Eyfjord, J. E., Thompson, A. M., Birney, E., Stunnenberg, H. G., van de Vijver, M. J., Martens, J. W. M., Børresen-Dale, A.-L., Richardson, A. L., Kong, G., Thomas, G., & Stratton, M. R.
- Affiliations
- Wellcome Sanger Institute (GB)
- Lund University (SE)
- Los Alamos National Laboratory (US)
- Erasmus MC (NL)
- Radboud University Nijmegen (NL)
- European Bioinformatics Institute (GB)
- Oslo University Hospital (NO)
- University of Oslo (NO)
- Gachon University Gil Medical Center (KR)
- Centre Léon Bérard (FR)
- Brigham and Women's Hospital (US)
- The Netherlands Cancer Institute (NL)
- Université Libre de Bruxelles (BE)
- University of Antwerp (BE)
- Dana-Farber Cancer Institute (US)
- Amsterdam UMC Location University of Amsterdam (NL)
- Asan Medical Center (KR)
- Hanyang University (KR)
- Memorial Sloan Kettering Cancer Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Institut National du Cancer (FR)
- Inserm (FR)
- Ninewells Hospital (GB)
- Institut Regional du Cancer de Montpellier (FR)
- The University of Queensland (AU)
- Istituto Tumori Bari (IT)
- University of Cambridge (GB)
- Institute of Cancer Research (GB)
- Haukeland University Hospital (NO)
- Singapore General Hospital (SG)
- Institut national de recherche en sciences et technologies du numérique (FR)
- Radboud University Medical Center (NL)
- University of Iceland (IS)
- Corresponding author
- Viari, Alain
- Kong, Gu
- Stratton, Michael R.
- ORCID
- Davies, Helen
- Staaf, Johan
- Ramakrishna, Manasa
- Zou, Xueqing
- Alexandrov, Ludmil B.
- Martin, Sancha
- Wedge, David C.
- Ju, Young Seok
- Smid, Marcel
- Brinkman, Arie B.
- Morganella, Sandro
- Aure, Miriam R.
- Lingjærde, Ole Christian
- Ringnér, Markus
- Ahn, Sung-Min
- Boyault, Sandrine
- Brock, Jane E.
- Broeks, Annegien
- Desmedt, Christine
- Dirix, Luc
- Dronov, Serge
- Gerstung, Moritz
- Hooijer, Gerrit K. J.
- Jang, Se Jin
- Jones, David R.
- Krishnamurthy, Savitri
- Lee, Hee Jin
- Lee, Jeong-Yeon
- Li, Yilong
- McLaren, Stuart
- Menzies, Andrew
- Mustonen, Ville
- Pivot, Xavier
- Purdie, Colin A.
- Raine, Keiran
- Ramakrishnan, Kamna
- Rodríguez-González, F. Germán
- Sieuwerts, Anieta M.
- Simpson, Peter T.
- Shepherd, Rebecca
- Teague, Jon
- Tommasi, Stefania
- Treilleux, Isabelle
- Vermeulen, Peter
- Yates, Lucy
- Caldas, Carlos
- Veer, Laura van’t
- Tutt, Andrew
- Knappskog, Stian
- Tan, Benita Kiat Tee
- Jonkers, Jos
- Borg, Åke
- Ueno, Naoto T.
- Sotiriou, Christos
- Viari, Alain
- Futreal, P. Andrew
- Span, Paul N.
- Lakhani, Sunil R.
- Thompson, Alastair M.
- Birney, Ewan
- Stunnenberg, Hendrik G.
- Martens, John W. M.
- Richardson, Andrea L.
- Kong, Gu
- Thomas, Gilles
- Stratton, Michael R.
- Venue
- Nature
- Published
- 2016-05-02
- Volume
- 534
- Issue
- 7605
- Pages
- 47-54
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4910866
- OpenAlex
- W2344657883
- Semantic Scholar
- abb27e35f11dcd60325f42f270b7811a4e852852
- Cited by
- 2,218
- References
- 60
- Citations by year
- 2026: 125 · 2025: 147 · 2024: 178 · 2023: 271 · 2022: 212 · 2021: 293 · 2020: 288 · 2019: 241 · 2018: 200 · 2017: 181 · 2016: 78
- FWCI
- 97.22
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-01-18)
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, other-oa)
- PubMed Central (acceptedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Apollo
- Funders
- U.S. Department of Energy (DE-AC52-06NA2-5396, AC52-06NA25396)
- Breast Cancer Research Foundation
- Dana-Farber/Harvard Cancer Center (P50 CA168504)
- University of Dundee
- Wellcome Trust (088177, 077012/Z/05/Z, 100183, 077012, WT100183MA, 098051)
- Francis Crick Institute (10202)
- QIMR Berghofer Medical Research Institute
- Cancer Research UK (60098573, 20952, CB4140, 16942)
- National Institute for Health and Care Research (NF-SI-0515-10090, NF-SI-0611-10154)
- Breast Cancer Campaign
- University of Cambridge
- European Commission (242006)
- National Research Foundation
- Icelandic Centre for Research
- Fonds De La Recherche Scientifique - FNRS
- Cancerfonden
- Cambridge University Hospitals (RG51913)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- National Research Foundation of Korea (2015R1A2A1A10052578, 2011-0030105)
- Vetenskapsrådet
- Háskóli Íslands
- Institut National Du Cancer
- Rannís
- National Institutes of Health (DE-AC52-06NA25396)
- National Nuclear Security Administration (DEAC52- 06NA25396)
- National Cancer Institute (CA168504, P30CA008748, P50CA168504)
- Los Alamos National Laboratory (AC52-06NA25396, DE-AC52-06NA25396)
- FP7 Ideas: European Research Council (322737)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- breast cancer, somatic mutations, driver mutations, mutational signatures, tandem duplication, homologous recombination deficiency, BRCA1, BRCA2, non-coding regions, intronic variants
- MeSH terms
- Breast Neoplasms, DNA Mutational Analysis, DNA Replication, DNA, Neoplasm, Female, Humans, Male, Mutation, Oncogenes, Cohort Studies, Genome, Human, Mutagenesis, Genes, BRCA1, Genomics, Genes, BRCA2, Mutation Rate, Recombinational DNA Repair
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
